Skip to content

Topic

drug approval

17 markets across Kalshi and Polymarket, $4.2K traded today.

MarketChance24hBest priceVolume 24h
FDA approves Retatrutide this year?Tech & ScienceEnds Dec 30, 20263%−2¢Polymarket3.9¢$2.4K
FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)EconomicsEnds Dec 31, 202689%—Kalshi92¢$703
Will the FDA approve any psychedelic substance for medical use this year?Tech & ScienceEnds Dec 31, 202626%—Kalshi29¢$554
FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)EconomicsEnds Dec 31, 202684%—Kalshi87¢$495
FDA decision: Ivonescimab by Summit Therapeutics (in 2026)EconomicsEnds Dec 31, 202685%—Kalshi88¢$28
Will the FDA approve cytisinicline for smoking cessation?Before Jan 1, 2027Tech & ScienceEnds Sep 30, 202614%—Kalshi18¢$20
When will the FDA approve Compass Pathways' COMP360 Psilocybin?Before Jan 1, 2027Tech & ScienceEnds Dec 31, 202636%—Kalshi39¢$12
When will the FDA approve Intellia Therapeutics' lonvo-z?Before July 2027Tech & ScienceEnds Jun 30, 202788%—Kalshi92¢$10
Will the FDA approve a cure for Type 1 diabetes before 2033?Tech & ScienceEnds Dec 31, 203239%—Kalshi39¢$1
Will the FDA approve VERVE-102?Before 2035Tech & ScienceEnds Dec 31, 202984%—Kalshi87¢—
Will the FDA approve MDMA for PTSD?Before Jan 1, 2032Tech & ScienceEnds Dec 31, 202655%—Kalshi58¢—
Will the FDA approve retatrutide?Before Jan 1, 2029Tech & ScienceEnds Dec 31, 202696%—Kalshi99¢—
Will the FDA approve intismeran autogene (V940/mRNA-4157)?Before Jan 1, 2028Tech & ScienceEnds Mar 31, 202793%—Kalshi95¢—
Will the FDA approve CagriSema?Before Jan 1, 2028Tech & ScienceEnds Sep 30, 202681%—Kalshi84¢—
FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)EconomicsEnds Dec 31, 202677%—Kalshi80¢—
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)EconomicsEnds Dec 31, 202689%—Kalshi92¢—
FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)EconomicsEnds Dec 31, 202691%—Kalshi93¢—